⌘K

Login Start Free

Home/Filings/4/0001562180-22-005314

4//SEC Filing

Koppel Adam 4

Accession 0001562180-22-005314

CIK 0001822462other

View on SEC.gov Company Profile

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 8:59 PM ET

Size

5.3 KB

Accession

0001562180-22-005314

Insider Transaction Report

Form 4

Period: 2022-06-21

Foghorn Therapeutics Inc.FHTX

Director

Transactions

Award
Stock Options (Right to buy)
2022-06-21+16,000→ 16,000 total
Exercise: $13.81From: 2023-06-21Exp: 2032-06-20→ Common Stock (16,000 underlying)

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

Foghorn Therapeutics Inc.

CIK 0001822462

Entity typeother

Related Parties

1

filerCIK 0001578965

Filing Metadata

Form type: 4
Filed: Jun 21, 8:00 PM ET
Accepted: Jun 22, 8:59 PM ET
Size: 5.3 KB

View on SEC.gov